|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06660 AIM VACCINE
Nominal 
1.865 +0.030 (+1.635%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 350,634 | -31.870% | 1,165,673 | 1,285,031 | 1,187,468 | 1,264,073 |
| Cost of Sales | (104,865) | -39.532% | (405,469) | (331,523) | (286,452) | (236,414) |
| Gross Profit | 245,769 | -27.977% | 760,204 | 953,508 | 901,016 | 1,027,659 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | (314,694) | (32,746) | (61,091) | -- | |
| Change in FV & Impairment on Others | (2,468) | -67.713% | (204,066) | 6,258 | (1,727,854) | (27,215) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (132,194) | -12.834% | (766,557) | (290,718) | (2,270,645) | (434,165) | |
| Taxation | 2,399 | -84.684% | 22,827 | 12,249 | 320,404 | 203,535 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 6,973 | 42.948% | 68,270 | 1,235 | 649,236 | (88,971) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (122,822) | -6.326% | (675,460) | (277,234) | (1,301,005) | (319,601) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 30,128 | 15.208% | 54,410 | 53,305 | 33,125 | 14,999 |
| Depreciation & Amortisation | 78,400 | -3.832% | 158,329 | 172,029 | 174,697 | 166,441 |
| Directors' Emoluments | -- | -- | -- | 9,606 | 8,035 | 78,463 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -10.000 | -9.091% | -55.000 | -23.000 | -107.000 | -27.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.055 | 0.082 | (0.137) | (0.092) |
| NBV per share ($) | 2.149 | -- | 2.250 | 2.779 | 3.008 | 4.096 |
| Remarks: | Real time quote last updated: 04/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -122,822 |
| %Change | -6.326% |
| EPS / (LPS) | RMB -0.100 |
| NBV Per Share (¥) | RMB 2.149 |